WASHINGTON, D.C.—The vast majority of the attention given to vasculitis at the ACR/ARHP Annual Meeting, year after year, focuses on ANCA-associated vasculitis and large-vessel vasculitis, said Philip Seo, MD, MHS, director of the Johns Hopkins Vasculitis Center and moderator of the 2016 ACR Review Course titled, Neglected Vasculitis. That leaves out a lot.
Explore this issueFebruary 2017
Also by this Author
“These are important diagnoses,” Dr. Seo said. “There have been a lot of advances made over the last several years. But does that mean there are lot of forms of vasculitis out there that you are going to run into on a regular basis that don’t get any love from the ACR? It’s hard to have an opinion about diagnoses that you don’t see on a daily basis.”
Dr. Seo described some of the ins and outs of three vasculitis forms that are less common: IgA vasculitis (formerly known as Henoch-Schönlein purpura), polyarteritis nodosa and urticarial vasculitis.